Facilitating Access to Approved Medication

Tremelimumab-ACTL Injection
Tremelimumab is indicated, for the treatment of adults with unresectable hepatocellular carcinoma.

Get Access To Tremelimumab-ACTL Injection

Ribociclib-tablets Available Price In India UK Saudi Arabia

Tremelimumab-ACTL Injection

  • API: tremelimumab-actl
  • Trade Name: On Request
  • Packaging: injection
  • Strength: Injection: 25 mg/1.25 mL (20 mg/mL) solution in a single-dose vial.
    Injection: 300 mg/15 mL (20 mg/mL) solution in a single-dose vial.
  • Indications:

What is Tremelimumab-ACTL Injection used for?

TREMELIMUMAB-ACTL is a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking antibody indicated in combination with durvalumab, for the treatment of adult patients with unresectable hepatocellular carcinoma (uHCC). Tremelimumab was approved for unresectable hepatocellular carcinoma medical use in the United States in October 2022.

Note: (For Prescribing Information Approved Drugs, see)

  • The Food and Drug Administration (FDA), USA.
  • The European Medicines Agency (EMA).

All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Tremelimumab-ACTL Injection is a pharmaceutical drug  To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.